Document

6-K 1 a240621_6kxmorxvotingright.htm 6-K Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2024

COMMISSION FILE NUMBER 001-38455

MorphoSys AG

Semmelweisstrasse 7

82152 Planegg

Germany

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

On June 21, 2024, MorphoSys AG (the “Company”) published a notification of major holdings from Novartis AG.

Exhibits

99.1 Notification of Major Holdings from Novartis AG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MORPHOSYS AG (Registrant)

Date: June 21, 2024

By: /s/ i.A. Inge Altinger-Ralle

Name: Inge Altinger-Ralle

Title: Specialist Corporate Publishing

By: /s/ i.A. Robert Mayer

Name: Robert Mayer

Title: Director Investor Relations

SEC Form 6-K filed by MorphoSys AG